BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 29388678)

  • 1. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.
    Dragoman MV; Tepper NK; Fu R; Curtis KM; Chou R; Gaffield ME
    Int J Gynaecol Obstet; 2018 Jun; 141(3):287-294. PubMed ID: 29388678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined oral contraceptives: venous thrombosis.
    de Bastos M; Stegeman BH; Rosendaal FR; Van Hylckama Vlieg A; Helmerhorst FM; Stijnen T; Dekkers OM
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010813. PubMed ID: 24590565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
    Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
    Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis.
    Stegeman BH; de Bastos M; Rosendaal FR; van Hylckama Vlieg A; Helmerhorst FM; Stijnen T; Dekkers OM
    BMJ; 2013 Sep; 347():f5298. PubMed ID: 24030561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data.
    Schink T; Princk C; Braitmaier M; Haug U
    BJOG; 2022 Dec; 129(13):2107-2116. PubMed ID: 35876787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
    Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Types of progestogens in combined oral contraception: effectiveness and side-effects.
    Lawrie TA; Helmerhorst FM; Maitra NK; Kulier R; Bloemenkamp K; Gülmezoglu AM
    Cochrane Database Syst Rev; 2011 May; (5):CD004861. PubMed ID: 21563141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
    Dragoman M; Curtis KM; Gaffield ME
    Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Risk for Venous Thromboembolism With Use of Low-Dose Extended- and Continuous-Cycle Combined Oral Contraceptives: A Safety Study Using the Sentinel Distributed Database.
    Li J; Panucci G; Moeny D; Liu W; Maro JC; Toh S; Huang TY
    JAMA Intern Med; 2018 Nov; 178(11):1482-1488. PubMed ID: 30285041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute and attributable risk of venous thromboembolism in women on combined cyproterone acetate and ethinylestradiol.
    Lidegaard Ø
    J Obstet Gynaecol Can; 2003 Jul; 25(7):575-7. PubMed ID: 12851669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
    Larivée N; Suissa S; Coulombe J; Tagalakis V; Filion KB
    Drug Saf; 2017 Jul; 40(7):583-596. PubMed ID: 28382493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
    Odlind V; Milsom I; Persson I; Victor A
    Acta Obstet Gynecol Scand; 2002 Jun; 81(6):482-90. PubMed ID: 12047300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis.
    Martínez F; Ramírez I; Pérez-Campos E; Latorre K; Lete I
    Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):7-29. PubMed ID: 22239262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal contraception and venous thromboembolism.
    Lidegaard Ø; Milsom I; Geirsson RT; Skjeldestad FE
    Acta Obstet Gynecol Scand; 2012 Jul; 91(7):769-78. PubMed ID: 22568831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.
    Farmer RD; Lawrenson RA; Todd JC; Williams TJ; MacRae KD; Tyrer F; Leydon GM
    Br J Clin Pharmacol; 2000 Jun; 49(6):580-90. PubMed ID: 10848722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.
    Larivée N; Suissa S; Khosrow-Khavar F; Tagalakis V; Filion KB
    BJOG; 2017 Sep; 124(10):1490-1499. PubMed ID: 28276140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.